Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-21-000015
Filing Date
2021-12-02
Accepted
2021-12-02 16:06:52
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20210930.htm   iXBRL 10-Q 1281380
2 EX-4.1 cntx-20210930x10qexhibit41.htm EX-4.1 119194
3 EX-10.3 cntx-20210930x10qexhibit103.htm EX-10.3 354965
4 EX-10.4 cntx-20210930x10qexhibit104.htm EX-10.4 200353
5 EX-31.1 cntx-20210930x10qexhibit311.htm EX-31.1 10214
6 EX-31.2 cntx-20210930x10qexhibit312.htm EX-31.2 10259
7 EX-32.1 cntx-20210930x10qexhibit321.htm EX-32.1 5666
  Complete submission text file 0001842952-21-000015.txt   6638782

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20210930.xsd EX-101.SCH 40338
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20210930_cal.xml EX-101.CAL 33925
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20210930_def.xml EX-101.DEF 254850
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20210930_lab.xml EX-101.LAB 519455
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20210930_pre.xml EX-101.PRE 351619
13 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20210930_htm.xml XML 882198
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 211466656
SIC: 2834 Pharmaceutical Preparations